Clinical Trials Directory

Trials / Completed

CompletedNCT05992246

The Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children

The Validity of the Ratio of Femoral Vein Diameter to Femoral Artery Diameter to Predict Fluid Responsiveness in Children

Status
Completed
Phase
Study type
Observational
Enrollment
85 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
2 Years – 10 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of the study will be that the ratio of femoral vein diameter to femoral artery diameter will have correlation with fluid status in pediatrics.

Detailed description

Proper administration of intravenous fluids is an important part of treating circulatory failure in children and affects the clinical outcome of the management of the child's emergency. Giving a small amount of fluid will cause tissue hypoperfusion and worsen organ dysfunction and cause ischemia. On the other hand, excess fluid interferes with oxygen delivary, exacerbates treatment outcomes, increases complications, and extends both the length of the stay in intensive care and mortality. The use of bedside ultrasound by pediatric intensive care physicians has become so critical in recent years that it is now a component of physical examination in ICUs

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRatio of Femoral Vein Diameter to Femoral Artery DiameterAn ultrasound probe will be used to first scan the area of the upper thigh just below the inguinal ligament directing caudally seeking for the femoral vessels. The femoral artery and vein could be observed simultaneously. Under normal conditions, pulsation is an indication of the femoral artery, and its companion is the femoral vein. The mean femoral vein diameter and femoral vein diameter (3-5 diametral lines in different directions) will be measured during cough, crying, or performing the Valsalva maneuvers.

Timeline

Start date
2023-08-20
Primary completion
2024-12-30
Completion
2025-01-30
First posted
2023-08-15
Last updated
2025-02-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05992246. Inclusion in this directory is not an endorsement.